Showing results (201-210 of 731) with videos related to

Sort By:
Pageof 74
Expert Opinion on Pharmacotherapy|May 23, 2015
BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanomaJuliet Richman, Juan Martin-Liberal, Stefan Diem, et al.
Expert Opinion on Pharmacotherapy|April 27, 2019
Current and emerging systemic therapies for cutaneous metastatic melanomaRobert Mason, Lewis Au, Alvaro Ingles Garces, et al.
International Journal of Cancer|July 10, 2026
10-Years of First-Line Ipilimumab and Nivolumab in Advanced Melanoma: A Single Centre ExperienceAnadil Javaid, Tobias Peres, Andreas Michael Schmitt, et al.
Expert Review of Anticancer Therapy|April 16, 2020
Avelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacyIsla Leslie, Laura Amanda Boos, James Larkin, et al.
The International Journal on Drug Policy|April 4, 2025
Prioritising research on marketing and consumption of No and Low (NoLo) alcoholic beverages in IrelandEmeka W Dumbili, Paula Leonard, James Larkin, et al.
Lancet (London, England)|December 7, 2020
Enhancing anti-tumour efficacy with immunotherapy combinationsFunda Meric-Bernstam, James Larkin, Josep Tabernero, et al.
Open Biology|January 13, 2021
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectoriesRobert E Hynds, Kristopher K Frese, David R Pearce, et al.
Molecular & Cellular Oncology|December 20, 2023
APOBEC3 as a driver of genetic intratumor heterogeneitySubramanian Venkatesan, Mihaela Angelova, Jirina Bartkova, et al.
Science Translational Medicine|April 17, 2015
Clonal status of actionable driver events and the timing of mutational processes in cancer evolutionNicholas McGranahan, Francesco Favero, Elza C de Bruin, et al.
Cancer Cell|April 29, 2022
The translational challenges of precision oncologyOriol Pich, Chris Bailey, Thomas B K Watkins, et al.
Pageof 74